Medications that target obesity are not typically covered by Medicare. When the FDA approved semaglutide as a way to treat certain cardiovascular risks, however, CMS said Medicare coverage was on the table. 

The company has entered into a definitive agreement to purchase Core Ventures, resulting in the Florida Cancer Specialists & Research Institute aligning with its oncology network.

Congress is considering two bills that would prevent or mitigate the Medicare physician payment cuts that went into effect in January 2024, and the Society for Cardiovascular Angiography and Interventions is urging members write their Congressmen.

Evolent is attracting interest from buyers, and a sale of the company could be finalized in weeks, sources claim.

New trends in venture capital activity represent a "positive sign" for the future, according to a new market analysis.

The lawsuit was brought by a whistleblower accusing the insurer of lying to earn Medicare Part D contracts from the Centers for Medicare & Medicaid Services.

V-Wave has gained considerable attention for its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and lungs of HFrEF patients.

The move makes it crystal clear that Edwards remains focused on pursuing advanced TAVR technologies. The company just acquired JenaValve, another company dedicated to developing new AR treatments, back in July.